Thromboprophylaxis and death after total hip replacement

The Journal of Bone and Joint Surgery. British Volume
D W MurrayChristopher K Bulstrode

Abstract

The recommendation that patients having a total hip replacement should receive pharmacological thromboprophylaxis is based on the belief that fatal pulmonary embolism is common, and that prophylaxis will decrease the death rate. To investigate these assumptions we performed a meta-analysis of all studies on hip replacement which included information about death or fatal pulmonary embolism. A total of 130 000 patients was included. The studies were so varied in content and quality that the results of our analysis must be interpreted with some caution. The fatal pulmonary embolism rate was 0.1% to 0.2% even in patients who received no prophylaxis. This is an order of magnitude lower than that which is generally quoted, and therefore the potential benefit of prophylaxis is small and may not justify the risks. To balance the risks and benefits we must consider the overall death rate. This was 0.3% to 0.4%, and neither heparin nor any other prophylactic agent caused a significant decrease. Our study demonstrates that there is not enough evidence in the literature to conclude that any form of pharmacological thromboprophylaxis decreases the death rate after total hip replacement. For this reason guidelines which recommend their routi...Continue Reading

Citations

Oct 15, 1998·Acta Orthopaedica Scandinavica. Supplementum·D Murray
Nov 3, 1998·Acta Orthopaedica Scandinavica·O E Dahl
Nov 11, 1999·Quality in Health Care : QHC·E FerlieL Fitzgerald
Feb 9, 2002·The Journal of Trauma·Sherif M AmrAhmed M Kholeif
Jun 7, 2003·Hospital Medicine·I J Brenkel, R E Cook
Mar 24, 2004·Calcified Tissue International·J LiA Kreicbergs
Mar 4, 2006·British Journal of Haematology·T BaglinUNKNOWN British Committee for Standards in Haematology
Sep 18, 2009·Journal of Thrombosis and Thrombolysis·K KrögerF Santosa
Apr 18, 2013·Orthopedics·Joseph P WardAndrew G Urquhart
Aug 16, 2015·Journal of Thrombosis and Thrombolysis·Carolin PütterKnut Kröger
Feb 4, 1999·Acta Orthopaedica Scandinavica·L M Hove, P T Nilsen
Dec 13, 2005·Anesthesia and Analgesia·Eugene R Viscusi
Feb 1, 2006·Clinical Orthopaedics and Related Research·Alejandro González Della ValleEduardo A Salvati
Aug 15, 2006·Clinical Orthopaedics and Related Research·Vincent D PellegriniC McCollister Evarts
Sep 8, 2006·Clinical Orthopaedics and Related Research·Paul A Lotke, Jess H Lonner
May 3, 2008·The Journal of Bone and Joint Surgery. British Volume·J DanielD J W McMinn
Jul 5, 2008·Annals of the Royal College of Surgeons of England·Mark R DunbarShanmugam Karthikeyan
Feb 12, 2008·Clinical Orthopaedics and Related Research·Nigel E SharrockEduardo A Salvati
Jan 12, 2011·International Orthopaedics·Ralf DieckmannJendrik Hardes
Sep 1, 2011·Clinical Orthopaedics and Related Research·Patricia HansenRichard H Rothman
Jan 6, 2012·The Journal of Bone and Joint Surgery. British Volume·L A PoultsidesE Salvati
Aug 28, 2013·Musculoskeletal Surgery·I SanzarelloM A Rosa
Feb 7, 2017·Sports Health·Amanda ArnoldEllen Shanley
Nov 24, 1999·Acta Orthopaedica Scandinavica·D P Thomas
Sep 28, 2001·Anesthesia and Analgesia·W S BeattieP Choi
Mar 6, 2004·Journal of Thrombosis and Haemostasis : JTH·A K KakkarUNKNOWN Investigators Against Thromboembolism (INATE) Core Group
Sep 29, 2006·Clinical Orthopaedics and Related Research·Paul F Lachiewicz, Elizabeth S Soileau
Mar 4, 2008·The Journal of Bone and Joint Surgery. British Volume·M ParryA W Blom
Feb 3, 2011·Irish Journal of Medical Science·C L DonohoeD M Niall
May 2, 2009·The Journal of Bone and Joint Surgery. British Volume·L A Cusick, D E Beverland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.